Edoxaban versus warfarin in patients with atrial fibrillation - The New England Journal of Medicine - 2013
Brief Summary:
Among patients with nonvalvular atrial fibrillation edoxaban is superior to warfarin in preventing stroke or systemic embolism and is associated with lower rates of bleeding and death from CV events.Reference: http://www.ncbi.nlm.nih.gov/pubmed/24251359
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you